Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection

被引:46
作者
Agrati, C. [1 ,2 ]
Castilletti, C. [1 ]
Casetti, R. [2 ]
Sacchi, A. [2 ]
Falasca, L. [3 ]
Turchi, F. [2 ]
Tumino, N. [2 ]
Bordoni, V. [2 ]
Cimini, E. [2 ]
Viola, D. [2 ]
Lalle, E. [1 ]
Bordi, L. [1 ]
Lanini, S. [4 ]
Martini, F. [2 ]
Nicastri, E. [5 ]
Petrosillo, N. [5 ]
Puro, V. [4 ]
Piacentini, M. [3 ]
Di Caro, A. [1 ]
Kobinger, G. P. [6 ]
Zumla, A. [7 ]
Ippolito, G. [4 ]
Capobianchi, M. R. [1 ]
机构
[1] INMI IRCCS L Spallanzani, Virol Lab, Rome, Italy
[2] INMI IRCCS L Spallanzani, Cellular Immunol Lab, Rome, Italy
[3] INMI L Spallanzani, Microscopy Lab, Rome, Italy
[4] INMI IRCCS L Spallanzani, Epidemiol Div, Rome, Italy
[5] INMI IRCCS L Spallanzani, Clin Div, Rome, Italy
[6] Publ Hlth Agcy Canada, Natl Lab Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada
[7] UCL, Div Infect & Immun, London, England
来源
CELL DEATH & DISEASE | 2016年 / 7卷
关键词
VIRUS INFECTION; HEMORRHAGIC-FEVER; IMMUNE ACTIVATION; DENDRITIC CELLS; RESPONSES; DEATH; CYTOMEGALOVIRUS; ENCEPHALITIS; PATHOGENESIS; PROTECTION;
D O I
10.1038/cddis.2016.55
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Data on immune responses during human Ebola virus disease (EVD) are scanty, due to limitations imposed by biosafety requirements and logistics. A sustained activation of T-cells was recently described but functional studies during the acute phase of human EVD are still missing. Aim of this work was to evaluate the kinetics and functionality of T-cell subsets, as well as the expression of activation, autophagy, apoptosis and exhaustion markers during the acute phase of EVD until recovery. Two EVD patients admitted to the Italian National Institute for Infectious Diseases, Lazzaro Spallanzani, were sampled sequentially from soon after symptom onset until recovery and analyzed by flow cytometry and ELISpot assay. An early and sustained decrease of CD4 T-cells was seen in both patients, with an inversion of the CD4/CD8 ratio that was reverted during the recovery period. In parallel with the CD4 T-cell depletion, a massive T-cell activation occurred and was associated with autophagic/apoptotic phenotype, enhanced expression of the exhaustion marker PD-1 and impaired IFN-gamma production. The immunological impairment was accompanied by EBV reactivation. The association of an early and sustained dysfunctional T-cell activation in parallel to an overall CD4 T-cell decline may represent a previously unknown critical point of Ebola virus (EBOV)-induced immune subversion. The recent observation of late occurrence of EBOV-associated neurological disease highlights the importance to monitor the immuno-competence recovery at discharge as a tool to evaluate the risk of late sequelae associated with resumption of EBOV replication. Further studies are required to define the molecular mechanisms of EVD-driven activation/exhaustion and depletion of T-cells.
引用
收藏
页码:e2164 / e2164
页数:8
相关论文
共 37 条
[1]   Association of Profoundly Impaired Immune Competence in H1N1v-Infected Patients with a Severe or Fatal Clinical Course [J].
Agrati, Chiara ;
Gioia, Cristiana ;
Lalle, Eleonora ;
Cimini, Eleonora ;
Castilletti, Concetta ;
Armignacco, Orlando ;
Lauria, Francesco Nicola ;
Ferraro, Federica ;
Antonini, Mario ;
Ippolito, Giuseppe ;
Capobianchi, Maria Rosaria ;
Martini, Federico .
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (05) :681-689
[2]  
[Anonymous], WHO EB SIT REP
[3]   Clinical features and pathobiology of Ebolavirus infection [J].
Ansari, Aftab A. .
JOURNAL OF AUTOIMMUNITY, 2014, 55 :1-9
[4]   Immune Evasion in Ebolavirus Infections [J].
Audet, Jonathan ;
Kobinger, Gary P. .
VIRAL IMMUNOLOGY, 2015, 28 (01) :10-18
[5]   Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients [J].
Baize, S ;
Leroy, EM ;
Georges-Courbot, MC ;
Capron, M ;
Lansoud-Soukate, J ;
Debré, P ;
Fisher-Hoch, SP ;
McCormick, JB ;
McCormick, JB ;
Georges, AJ .
NATURE MEDICINE, 1999, 5 (04) :423-426
[6]   Inflammatory responses in Ebola virus-infected patients [J].
Baize, S ;
Leroy, EM ;
Georges, AJ ;
Georges-Courbot, MC ;
Capron, M ;
Bedjabaga, I ;
Lansoud-Soukate, J ;
Mavoungou, E .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) :163-168
[7]   The Ebola virus VP35 protein functions as a type IIFN antagonist [J].
Basler, CF ;
Wang, XY ;
Mühlberger, E ;
Volchkov, V ;
Paragas, J ;
Klenk, HD ;
Garcia-Sastre, A ;
Palese, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12289-12294
[8]   Evasion of Interferon Responses by Ebola and Marburg Viruses [J].
Basler, Christopher F. ;
Amarasinghe, Gaya K. .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (09) :511-520
[9]   Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation [J].
Bosio, CM ;
Aman, MJ ;
Grogan, C ;
Hogan, R ;
Ruthel, G ;
Negley, D ;
Mohamadzadeh, M ;
Bavari, S ;
Schmaljohn, A .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) :1630-1638
[10]   Lymphocyte death in a mouse model of Ebola virus infection [J].
Bradfute, Steven B. ;
Braun, Denise R. ;
Shamblin, Joshua D. ;
Geisbert, Joan B. ;
Paragas, Jason ;
Garrison, Aura ;
Hensley, Lisa E. ;
Geisbert, Thomas W. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 :S296-S304